Results 11 to 20 of about 22,288 (223)
Radiation therapy for neovascular age-related macular degeneration
Clinical Ophthalmology, 2011 Robert Petrarca, Timothy L JacksonDepartment of Ophthalmology, King’s College Hospital NHS Foundation Trust, London, UKAbstract: Antivascular endothelial growth factor (anti-VEGF) therapies represent the standard of care for most patients ...
Robert Petrarca, Timothy L Jackson
doaj +2 more sources
Treatment of neovascular age-related macular degeneration in patients with diabetes
Clinical Ophthalmology, 2008 Michael Cummings1, José Cunha-Vaz21Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Portsmouth, UK; 2Department of Ophthalmology, University Hospital of Coimbra, Centre of Ophthalmology, Institute of Biomedical ...
Michael Cummings +1 more
doaj +1 more source
International Medical Case Reports JournalJakob Pericak,1,2 Eric K Chin,3,4 David RP Almeida2 1State University of New York at Geneseo, Geneseo, NY, USA; 2Erie Retina Research & Center for Advanced Surgical Exploration, Erie, PA, USA; 3Retina Consultants of Southern California, Redlands, CA, USA;
Pericak J, Chin EK, Almeida DRP
doaj +2 more sources
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
Clinical Ophthalmology, 2008 Sobha Sivaprasad, Nachiketa Acharya, Phil HykinMoorfields Eye Hospital, London, UKAbstract: The pathogenesis of age-related macular degeneration (AMD) is unclear, but it can take either a neovascular/exudative/wet form, characterized by choroidal ...
Sobha Sivaprasad +2 more
doaj +1 more source
Estimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by ranibizumab treatment. [PDF]
PLoS ONE, 2014 Intravitreal injections of anti-vascular endothelial growth factor agents, such as ranibizumab, have significantly improved the management of neovascular age-related macular degeneration. This study used patient-level simulation modelling to estimate the
Paul Mitchell +9 more
doaj +1 more source
Radiotherapy for neovascular age-related macular degeneration [PDF]
Cochrane Database of Systematic Reviews, 2010 Radiotherapy has been proposed as a treatment to prevent new vessel growth in people with neovascular age-related macular degeneration (AMD).The aim of this review was to examine the effects of radiotherapy on neovascular AMD.We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Group ...
Evans, JR, Sivagnanavel, V, Chong, V
openaire +4 more sources
Novel approach to antiangiogenic factors in age-related macular degeneration therapy
Central European Journal of Immunology, 2022 Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the population above 85 worldwide. There are two main types of AMD: neovascular and dry AMD.
Katarzyna Samelska +4 more
doaj +1 more source
Bacillary Layer Detachment in Neovascular Age-Related Macular Degeneration: Case Series
Biomedicines, 2023 Purpose: This study seeks to report the clinical and multimodal imaging findings of eight eyes of seven patients with neovascular age-related macular degeneration (nAMD) who developed bacillary layer detachment (BALAD).
Filomena Palmieri +3 more
doaj +1 more source
Folia Medica, 2019 Age-related macular degeneration is a leading cause of irreversible vision loss in individuals over 55 years of age worldwide. Conventionally, it is divided into two subtypes – dry (non-neovascular) and wet (neovascular) form.
Stavrev Vladimir N. +2 more
doaj +1 more source
Modelling the Genetic Risk in Age-Related Macular Degeneration [PDF]
, 2012 Late-stage age-related macular degeneration (AMD) is a common sight-threatening disease of the central retina affecting approximately 1 in 30 Caucasians.
Weber, Bernhard H. F. +29 more
core +1 more source